EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease–mineral bone disorder-Reference-Cited by-同舟云学术

EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease–mineral bone disorder

Published:2020-08 Issue:2 Volume:98 Page:343-354
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Tsuboi Yoshinori,Ohtomo Shuichi,Ichida Yasuhiro,Hagita Hitoshi,Ozawa Kazuharu,Iida Manami,Nagao Shunsuke,Ikegami Hisashi,Takahashi Tadakatsu,Horiba Naoshi

Publisher

Elsevier BV

Subject

Nephrology

Reference46 articles.

1. Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease;Staude;Kidney Blood Press Res,2013

2. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism;Slatopolsky;Am J Kidney Dis,2001

3. The mechanism of phosphorus as a cardiovascular risk factor in CKD;Mathew;J Am Soc Nephrol,2008

4. Serum phosphate levels and mortality risk among people with chronic kidney disease;Kestenbaum;J Am Soc Nephrol,2005

5. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis;Block;J Am Soc Nephrol,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province;BMJ Open;2024-08

2. Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs;Expert Opinion on Investigational Drugs;2024-06-19

3. Adenine-induced animal model of chronic kidney disease: current applications and future perspectives;Renal Failure;2024-04-04

4. Effect of an NHE3 inhibitor in combination with an NPT2b inhibitor on gastrointestinal phosphate absorption in Rodent models;PLOS ONE;2024-01-26

5. The basics of phosphate metabolism;Nephrology Dialysis Transplantation;2023-09-02